Table: Cosmos Pharmaceutical -2019/20 group results

Cosmos Pharmaceutical

10/07/2020 07:00

Jul 10 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2020    May 31, 2019   May 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          684.40          611.14         723.00        361.00   
               (+12.0 pct)     (+9.5 pct)     (+5.6 pct)   (+11.0 pct) 
  Operating       29.09           24.78          29.10         15.00   
               (+17.4 pct)     (+8.9 pct)     (+0.0 pct)   (+25.4 pct) 
  Recurring       31.56           27.29          31.60         16.15   
               (+15.6 pct)     (+8.1 pct)     (+0.1 pct)   (+23.2 pct) 
  Net
  Net             21.44           19.19          21.78         11.02   
               (+11.7 pct)     (+8.8 pct)     (+1.6 pct)   (+25.6 pct) 
  EPS          541.30 yen      484.48 yen     550.01 yen    278.29 yen 
  Ann Div      110.00 yen      100.00 yen      55.00 yen               
  -Q2 Div       50.00 yen       45.00 yen      27.50 yen               
  -Q4 Div       60.00 yen       55.00 yen      27.50 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T